Sign In
Buy SLP
$16.17
-0.600 (-3.58%)
At Close: Jun 03, 2026
3 Software Stocks to Watch as the Industry Gains Momentum
09:36am, Tuesday, 09'th Dec 2025
Steady digital transformation and strong adoption of AI bode well for Computer Software industry participants like SNPS, DSGX and SLP amid broader market volatility.
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development
Why Shares of Simulations Plus Soared This Week
12:30pm, Thursday, 04'th Dec 2025
The stock has taken a beating over the past few years, so expectations may have been low.
Simulations Plus: Buying On Long-Term Silico Drug-Development
09:41pm, Tuesday, 02'nd Dec 2025
Simulations Plus is a specialized in silico software-and-services platform. They help with model-informed, non-animal drug development. SLP's services help across discovery, development, and clinical
Why Simulations Plus Stock Was Soaring Today
03:40pm, Tuesday, 02'nd Dec 2025
Its full-year fiscal 2025 featured a double-digit revenue increase. As for the fourth quarter, its performance was mixed.
Simulations Plus Stock Climbs On Earnings Strength, Biotech Market Rebound
12:52pm, Tuesday, 02'nd Dec 2025
Simulations Plus Inc. (NASDAQ: SLP) shares climbed on Tuesday after the company reported better-than-expected fourth-quarter 2025 earnings and reaffirmed annual guidance.
Simulations Plus' Q4 Earnings & Sales Meet Estimates, Fall Y/Y
10:11am, Tuesday, 02'nd Dec 2025
SLP posts softer fiscal Q4 2025 results but meets full-year goals as cloud, AI and integrated workflows shape its next growth phase.
Simulations Plus, Inc. (SLP) Q4 2025 Earnings Call Transcript
08:13pm, Monday, 01'st Dec 2025
Simulations Plus, Inc. (SLP) Q4 2025 Earnings Call Transcript
Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results
04:05pm, Monday, 01'st Dec 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in cheminformatics, biosimulation, clinical operation
First Look: Airbus drops, Crypto slides, Cyber Monday
07:37am, Monday, 01'st Dec 2025
Stock News Airbus shares sink on fresh A320 quality snag: Airbus (EADSY) fell after reports of an industrial quality issue affecting fuselage panels on dozens o
NEWTOWN, Pa. , Nov. 28, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Simulations Plus, Inc. (NASDAQ: SLP), resulting from a
Simulations Plus (SLP) Reports Next Week: Wall Street Expects Earnings Growth
11:01am, Monday, 24'th Nov 2025
Simulations Plus (SLP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Simulations Plus, Inc. - SLP
10:00am, Thursday, 20'th Nov 2025
NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. ("Simulations Plus" or the "Company") (NASDAQ: SLP). Such investors
Analyzing The Descartes Systems Group (NASDAQ:DSGX) & Simulations Plus (NASDAQ:SLP)
01:16am, Wednesday, 19'th Nov 2025
Simulations Plus (NASDAQ: SLP - Get Free Report) and The Descartes Systems Group (NASDAQ: DSGX - Get Free Report) are both computer and technology companies, but which is the better stock? We will com
Campbell & CO Investment Adviser LLC Acquires Shares of 13,581 Simulations Plus, Inc. $SLP
03:52am, Tuesday, 18'th Nov 2025
Campbell and CO Investment Adviser LLC acquired a new stake in Simulations Plus, Inc. (NASDAQ: SLP) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Comm
